These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Kappa-opioid potentiation of tumor necrosis factor-alpha-induced anti-HIV-1 activity in acutely infected human brain cell cultures. Chao CC; Gekker G; Hu S; Kravitz F; Peterson PK Biochem Pharmacol; 1998 Aug; 56(3):397-404. PubMed ID: 9744578 [TBL] [Abstract][Full Text] [Related]
9. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain. Devlin T; Shoemaker WJ J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019 [TBL] [Abstract][Full Text] [Related]
10. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor. Kong H; Raynor K; Yano H; Takeda J; Bell GI; Reisine T Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8042-6. PubMed ID: 8058754 [TBL] [Abstract][Full Text] [Related]
11. In vitro evidence for a dual role of tumor necrosis factor-alpha in human immunodeficiency virus type 1 encephalopathy. Wilt SG; Milward E; Zhou JM; Nagasato K; Patton H; Rusten R; Griffin DE; O'Connor M; Dubois-Dalcq M Ann Neurol; 1995 Mar; 37(3):381-94. PubMed ID: 7695238 [TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor. Raynor K; Kong H; Hines J; Kong G; Benovic J; Yasuda K; Bell GI; Reisine T J Pharmacol Exp Ther; 1994 Sep; 270(3):1381-6. PubMed ID: 7932192 [TBL] [Abstract][Full Text] [Related]
14. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting. Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155 [TBL] [Abstract][Full Text] [Related]
15. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein. Lawrence DM; Bidlack JM J Pharmacol Exp Ther; 1993 Sep; 266(3):1678-83. PubMed ID: 8103800 [TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory activity of mu- and kappa-selective opioid agonists. Taub DD; Eisenstein TK; Geller EB; Adler MW; Rogers TJ Proc Natl Acad Sci U S A; 1991 Jan; 88(2):360-4. PubMed ID: 1846441 [TBL] [Abstract][Full Text] [Related]
17. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure. Joseph DB; Bidlack JM J Pharmacol Exp Ther; 1995 Mar; 272(3):970-6. PubMed ID: 7891351 [TBL] [Abstract][Full Text] [Related]
18. Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism. Madamba SG; Schweitzer P; Siggins GR J Neurophysiol; 1999 Oct; 82(4):1768-75. PubMed ID: 10515966 [TBL] [Abstract][Full Text] [Related]
19. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. Schoffelmeer AN; Hogenboom F; Mulder AH Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509 [TBL] [Abstract][Full Text] [Related]
20. Depolarization regulates selectively the expression of different opioid receptors: a decreased number of kappa receptors in chronically activated guinea pig brain cell cultures. Barg J; Simantov R Neurosci Lett; 1990 Mar; 111(1-2):222-7. PubMed ID: 2159602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]